Tom Meade
Impact in
- Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
- Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects
Papers in
-
- Inflammatory mediators and NSAID effects 5
-
- Antiplatelet Therapy and Cardiovascular Diseases 2
- Co-authors
- Peter Malcolm Rothwell (5 shared papers)Jill JF Belch (4 shared papers)Charles P Warlow (3 shared papers)Michelle Wilson (3 shared papers)F.G.R. Fowkes (2 shared papers)Hisao Ogawa (2 shared papers)Ziyah Mehta (2 shared papers)Carl‐Eric Elwin (1 shared paper)
- Journals
- The Lancet (10 papers)International Journal of Epidemiology (3 papers)European Heart Journal (2 papers)American Journal of Epidemiology (2 papers)Obstetrical & Gynecological Survey (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Tom Meade
43 papers receiving 8.4k citations
Tom Meade's Hit Papers
Peers
Comparison fields: 5 of 166
- Internal Medicine 318
- Pharmacology 1.4k
- Cardiology and Cardiovascular Medicine 1.6k
- Cancer Research 872
- Endocrinology, Diabetes and Metabolism 792
Countries citing papers authored by Tom Meade
This map shows the geographic impact of Tom Meade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Meade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Meade more than expected).
Fields of papers citing papers by Tom Meade
This network shows the impact of papers produced by Tom Meade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Meade. The network helps show where Tom Meade may publish in the future.
Co-authors
The 25 scholars most cited alongside Tom Meade, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials Hit paper breakdown → | 2010 | 1237 |
| 2 | Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Hit paper breakdown → | 2010 | 1125 |
| 3 | SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe Hit paper breakdown → | 2021 | 1121 |
| 4 | World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions Hit paper breakdown → | 2019 | 836 |
| 5 | Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials Hit paper breakdown → | 2012 | 828 |
| 6 | Association of Cardiometabolic Multimorbidity With Mortality Hit paper breakdown → | 2015 | 820 |
| 7 | Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials Hit paper breakdown → | 2012 | 710 |
| 8 | PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study Hit paper breakdown → | 2016 | 314 |
| 9 | Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial Hit paper breakdown → | 2019 | 264 |
| 10 | Cardiovascular Risk Factors Associated With Venous Thromboembolism Hit paper breakdown → | 2019 | 258 |
| 11 | 2012 | 209 | |
| 12 | 2007 | 192 | |
| 13 | 2006 | 145 | |
| 14 | 2018 | 133 | |
| 15 | 1999 | 66 | |
| 16 | 1997 | 53 | |
| 17 | 2011 | 50 | |
| 18 | 2013 | 50 | |
| 19 | 2007 | 44 | |
| 20 | 2007 | 40 |
About Tom Meade
Tom Meade is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Internal Medicine, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 43 papers that have together received 8.7k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), Lipoproteins and Cardiovascular Health (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Menopause: Health Impacts and Treatments (3 papers), Statistical Methods in Clinical Trials (2 papers), Chronic Disease Management Strategies (2 papers), Ethics in Clinical Research (2 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). The work is most often cited by research in Internal Medicine (318 citations), Pharmacology (1.4k citations), Cardiology and Cardiovascular Medicine (1.6k citations), Cancer Research (872 citations) and Endocrinology, Diabetes and Metabolism (792 citations). Tom Meade has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Peter Malcolm Rothwell, Jill JF Belch, Charles P Warlow, Michelle Wilson, F.G.R. Fowkes, Hisao Ogawa, Ziyah Mehta, Carl‐Eric Elwin, Ale Algra and Bo Norrving. Their work appears in journals such as The Lancet, International Journal of Epidemiology, European Heart Journal, American Journal of Epidemiology and Obstetrical & Gynecological Survey.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.